You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Cancer despite immunosurveillance: immunoselection and immunosubversion
|
|---|---|
| Published in |
Nature Reviews Immunology, September 2006
|
| DOI | 10.1038/nri1936 |
| Pubmed ID | |
| Authors |
Laurence Zitvogel, Antoine Tesniere, Guido Kroemer |
| Abstract |
Numerous innate and adaptive immune effector cells and molecules participate in the recognition and destruction of cancer cells, a process that is known as cancer immunosurveillance. But cancer cells avoid such immunosurveillance through the outgrowth of poorly immunogenic tumour-cell variants (immunoselection) and through subversion of the immune system (immunosubversion). At the early stages of carcinogenesis, cell-intrinsic barriers to tumour development seem to be associated with stimulation of an active antitumour immune response, whereas overt tumour development seems to correlate with changes in the immunogenic properties of tumour cells. The permanent success of treatments for cancer might depend on using immunogenic chemotherapy to re-establish antitumour immune responses. |
Mendeley readers
The data shown below were compiled from readership statistics for 1,048 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | <1% |
| Italy | 4 | <1% |
| Mexico | 4 | <1% |
| Argentina | 3 | <1% |
| France | 2 | <1% |
| Spain | 2 | <1% |
| Brazil | 2 | <1% |
| Belgium | 2 | <1% |
| Canada | 2 | <1% |
| Other | 11 | 1% |
| Unknown | 1009 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 211 | 20% |
| Researcher | 167 | 16% |
| Student > Master | 160 | 15% |
| Student > Bachelor | 112 | 11% |
| Student > Doctoral Student | 53 | 5% |
| Other | 155 | 15% |
| Unknown | 190 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 278 | 27% |
| Medicine and Dentistry | 200 | 19% |
| Biochemistry, Genetics and Molecular Biology | 170 | 16% |
| Immunology and Microbiology | 96 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 25 | 2% |
| Other | 66 | 6% |
| Unknown | 213 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2024.
All research outputs
#2,124,704
of 25,837,817 outputs
Outputs from Nature Reviews Immunology
#842
of 2,693 outputs
Outputs of similar age
#4,179
of 89,086 outputs
Outputs of similar age from Nature Reviews Immunology
#4
of 19 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,693 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.0. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 89,086 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.